Xoma Corporation (XOMAO)

Überblick Nachrichten Preisverlauf Financials Forum Prognose Dividendenhistorie

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Xoma Corporation Stock (XOMAO) Company Profile

Xoma Corporation

Healthcare (1113)

Biotechnology (620)

510 204 7200

2200 Powell Street, Suite 310, EmeryVille

Nächster Verdiensttermin

Neueste SEC-Einreichungen

XOMAO's Discussions on Twitter

Compare XOMAO vs VRTX, REGN, ARGX, ALNY, ONC

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
XOMAO Xoma Corporation	25.39	0	0	0	0	0.00
VRTX Vertex Pharmaceuticals Inc	475.73	120.48B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	779.95	81.05B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	747.58	46.33B	4.16B	1.29B	734.26M	19.59
ALNY Alnylam Pharmaceuticals Inc	323.38	42.26B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	295.69	32.87B	5.36B	287.73M	924.18M	2.5229

Xoma Corporation Aktie (XOMAO) Neueste Nachrichten

Finanzdaten der Xoma Corporation-Aktie (XOMAO)

Es liegen keine Finanzdaten für Xoma Corporation (XOMAO) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Xoma Corporation (XOMAO)

Xoma Corporation Stock (XOMAO) Company Profile

Compare XOMAO vs VRTX, REGN, ARGX, ALNY, ONC

Xoma Corporation Aktie (XOMAO) Neueste Nachrichten

Layoff Watch: Why is XOMA Royalty Corporation stock going downJuly 2025 WrapUp & Precise Swing Trade Alerts - baoquankhu1.vn

Responsive Playbooks and the XOMAP Inflection - Stock Traders Daily

XOMA Royalty Corporation (NASDAQ:XOMA) Short Interest Update - MarketBeat

XOMA: Diversified royalty portfolio, multiple phase III catalysts, and profitability targeted by 2027 - TradingView

XOMA: Biotech royalty aggregator grew to 100+ assets, with strong cash flow and key 2026 milestones ahead - TradingView

XOMA Highlights Royalty Aggregation Strategy in Updated Presentation - TipRanks

XOMA (NASDAQ: XOMA) details 2025 royalty cash, buybacks and litigation costs - Stock Titan

(XOMAO) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily

Liquidity Mapping Around (XOMA) Price Events - Stock Traders Daily

LVTX Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

XOMA Royalty Corporation (XOMA) Stock Analysis: Unveiling A 145.89% Potential Upside - DirectorsTalk Interviews

What Analysts Are Saying About XOMA Royalty Stock - Sahm

Leerink raises Xoma stock price target on royalty outlook - Investing.com

XOMA Royalty Corporation (NASDAQ:XOMA) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

XOMA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

MURAMural Oncology PLC Latest Stock News & Market Updates - Stock Titan

What drives XOMA Royalty Corporation’s stock price2025 Analyst Calls & Short-Term High Return Ideas - mfd.ru

Understanding the Setup: (XOMAP) and Scalable Risk - Stock Traders Daily

Turnstone Biologics Corp. Enters into Agreement to be Acquired by XOMA Royalty Corporation for $0.34 in Cash Per Share Plus a Contingent Value Right - Intellectia AI

XOMA Royalty Corporation (XOMA) Stock Analysis: Unlocking a Potential 164.89% Upside with Strategic Biotech Ventures - DirectorsTalk Interviews

XOMA Royalty to Present at Investor Conferences in March - The Globe and Mail

Biotech royalty player XOMA lines up March investor talks - Stock Titan

How (XOMAO) Movements Inform Risk Allocation Models - Stock Traders Daily

Why (XOMA) Price Action Is Critical for Tactical Trading - Stock Traders Daily

Short Interest in XOMA Royalty Corporation (NASDAQ:XOMA) Grows By 27.4% - MarketBeat

Why analysts remain bullish on XOMA stockJuly 2025 Chart Watch & High Yield Stock Recommendations - mfd.ru

Why XOMA Royalty Corporation stock is rated strong buyJuly 2025 Outlook & Verified Swing Trading Watchlists - mfd.ru

TD Cowen Maintains XOMA Corp(XOMA.US) With Hold Rating - 富途牛牛

Xoma stock rating reinstated as Hold by TD Cowen after Generation Bio acquisition - Investing.com Australia

XOMA Royalty Corporation (XOMA): Investor Outlook with a Promising 177% Potential Upside - DirectorsTalk Interviews

Buyback Watch: What drives XOMA Royalty Corporations stock priceJuly 2025 Market Mood & Risk Controlled Stock Alerts - baoquankhu1.vn

Can XOMA Royalty Corporation maintain its current growth rateTrade Risk Report & Fast Entry and Exit Trade Plans - mfd.ru

Is XOMA Royalty Corporation forming a breakout pattern2025 Volatility Report & Free Expert Approved Momentum Trade Ideas - mfd.ru

XOMA Royalty’s Preferreds Still Offer Compelling Income Despite Call Risk (NASDAQ:XOMA) - Seeking Alpha

Growth Value: Can XOMA Royalty Corporation deliver alphaEarnings Risk Summary & Capital Efficient Trade Techniques - baoquankhu1.vn

Is XOMA Royalty Corporation's (NASDAQ:XOMA) 20% ROE Strong Compared To Its Industry? - simplywall.st

Generation Bio pays landlord $21.5M to escape lease early after Xoma buyout - The Business Journals

XOMA Royalty completes acquisition of Generation Bio for $4.29 per share - Investing.com Australia

XOMA Royalty completes acquisition of Generation Bio for $4.29 per share By Investing.com - Investing.com South Africa

Street Watch: What is the next catalyst for XOMA Royalty CorporationJuly 2025 Macro Moves & Trade Opportunity Analysis - baoquankhu1.vn

XOMA Royalty completes acquisition of Generation Bio; GBIO delisted from Nasdaq - Investing.com

XOMA Completes Acquisition and Delisting of Generation Bio - TipRanks

XOMA Royalty Completes Generation Bio Acquisition and Merger - TipRanks

XOMA Royalty Corporation Completes Acquisition of Generation Bio Co. Through Tender Offer - Quiver Quantitative

Generation Bio investors cashed out at $4.2913 a share in XOMA takeover - Stock Titan

XOMA Royalty Announces Closing of Tender Offer and Completed Acquisition of Generation Bio, Inc. - Sahm

The Technical Signals Behind (XOMAP) That Institutions Follow - Stock Traders Daily

The Future of Kinnate Biopharma Now Rests with Contingent Value Rights - AD HOC NEWS

Hillevax Acquisition Finalized: Shareholder Payouts and Future Rights Explained - AD HOC NEWS

Published on: 2026-02-09 02:34:15 - baoquankhu1.vn

Movement Recap: Will XOMA Royalty Corporation outperform its industry peersWeekly Earnings Recap & Free Weekly Watchlist of Top Performers - baoquankhu1.vn

Finanzdaten der Xoma Corporation-Aktie (XOMAO)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie XOMAO